When should patients with heterozygous familial hypercholesterolemia be treated?

JAMA. 1999 Jan 13;281(2):180-1. doi: 10.1001/jama.281.2.180.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adolescent
  • Adult
  • Anticholesteremic Agents / therapeutic use*
  • Child
  • Heterozygote
  • Humans
  • Hyperlipoproteinemia Type II / drug therapy*

Substances

  • Anticholesteremic Agents